Michelle S Ginsberg Selected Research

DNA (Deoxyribonucleic Acid)

11/2014	Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.
2/2012	Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle S Ginsberg Research Topics

Disease

27	Neoplasms (Cancer) 11/2021 - 01/2002
20	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2002
12	Adenocarcinoma of Lung 01/2022 - 03/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2002
10	Renal Cell Carcinoma (Grawitz Tumor) 09/2013 - 02/2003
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
4	Disease Progression 01/2020 - 12/2011
4	Malignant Mesothelioma 07/2019 - 06/2014
4	Adenocarcinoma 04/2016 - 03/2005
3	Fatigue 01/2016 - 12/2010
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2012 - 10/2007
2	Hemorrhage 01/2022 - 03/2009
2	Pulmonary Embolism 11/2018 - 06/2008
2	Anemia 01/2016 - 06/2006
2	Embolism (Embolus) 09/2014 - 11/2002
2	Rectal Neoplasms (Rectal Cancer) 08/2013 - 05/2008
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2012 - 12/2011
2	Stomatitis 05/2007 - 06/2003
1	Heart Neoplasms 01/2021
1	COVID-19 12/2020
1	Thrombosis (Thrombus) 06/2020
1	Mesothelioma 07/2019
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Cysts 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2016
1	Leukopenia 01/2016
1	Edema (Dropsy) 01/2016
1	Pleural Effusion (Pleural Effusions) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 11/2014
1	Hemoptysis 08/2013
1	Thymus Neoplasms (Thymus Neoplasm) 07/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Brain Neoplasms (Brain Tumor) 02/2012

Drug/Important Bio-Agent (IBA)

10	Sunitinib (Sutent)FDA Link 09/2013 - 01/2006
8	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2009
7	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2009
7	Gefitinib (Iressa)FDA Link 07/2011 - 12/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012 - 01/2006
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2011 - 09/2007
4	Bevacizumab (Avastin)FDA Link 01/2016 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2012
3	Pemetrexed (MTA)FDA Link 04/2016 - 06/2014
3	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 10/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2007
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 01/2016
2	GadoliniumIBA 01/2021 - 06/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2009
2	CrizotinibIBA 01/2017 - 08/2015
2	cabozantinibIBA 12/2016 - 08/2015
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2016 - 06/2014
2	Docetaxel (Taxotere)FDA Link 04/2016 - 05/2007
2	Gemcitabine FDA Link 04/2016 - 06/2014
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 11/2014
2	MethyltransferasesIBA 11/2014 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 02/2012
2	Temozolomide (Temodar)FDA LinkGeneric 11/2014 - 02/2012
2	Everolimus FDA Link 04/2012 - 12/2011
2	TOR Serine-Threonine KinasesIBA 04/2012 - 12/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012 - 01/2006
2	obatoclaxIBA 12/2011 - 11/2010
2	Topotecan (Hycamtin)FDA LinkGeneric 12/2011 - 11/2010
2	Pharmaceutical PreparationsIBA 08/2011 - 09/2007
2	Cetuximab (Erbitux)FDA Link 04/2011 - 02/2003
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2010 - 01/2006
1	ponatinibIBA 01/2022
1	trametinibIBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2020
1	IodineIBA 11/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Protein Subunit VaccinesIBA 12/2017
1	antineoplaston A10 (A 10)IBA 12/2016
1	Carboplatin (JM8)FDA LinkGeneric 04/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	PlatinumIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016
1	Alkylating AgentsIBA 11/2014
1	Fluorine-18IBA 10/2014
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 09/2014
1	Isoflurophate (DFP)FDA Link 09/2012
1	Sorafenib (BAY 43-9006)FDA Link 12/2011
1	farnesylthiosalicylic acidIBA 08/2011

Therapy/Procedure

17	Therapeutics 01/2020 - 01/2002
9	Drug Therapy (Chemotherapy) 10/2016 - 01/2002
5	Radiotherapy 01/2020 - 10/2014
4	Immunotherapy 11/2021 - 09/2017
4	Neoadjuvant Therapy 04/2016 - 05/2008
2	Chemoradiotherapy 01/2021 - 05/2008
2	Ambulatory Care (Outpatient Care) 12/2020 - 06/2008
1	Catheters 06/2020
1	Central Venous Catheters 06/2020
1	Pneumonectomy (Lung Volume Reduction) 10/2016
1	Contraindications 01/2016
1	Adjuvant Chemotherapy 08/2013
1	Thymectomy 07/2013